Page last updated: 2024-08-23

lovastatin and Graft vs Host Disease

lovastatin has been researched along with Graft vs Host Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bassett, R; Champlin, RE; Couriel, DR; Jones, D; Khalili, J; Komanduri, KV; Li, D; Ma, Q; Molldrem, JJ; Sale, GE; Wang, Y1
Brandl, U; Detter, C; Kreuzer, E; Kur, F; Mair, H; Meiser, BM; Seidel, D; Thiery, J; Uberfuhr, P; Wenke, K1

Trials

1 trial(s) available for lovastatin and Graft vs Host Disease

ArticleYear
Prevention and treatment of graft vessel disease after heart transplantation.
    Transplantation proceedings, 1995, Volume: 27, Issue:3

    Topics: Adult; Arteriosclerosis; Blood Component Removal; Cholesterol; Double-Blind Method; Female; Graft Occlusion, Vascular; Graft vs Host Disease; Heart Transplantation; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Oligopeptides; Peptides, Cyclic; Prospective Studies; Risk Factors; Simvastatin; Somatostatin; Tissue Donors

1995

Other Studies

1 other study(ies) available for lovastatin and Graft vs Host Disease

ArticleYear
Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:12

    Topics: Animals; Bone Marrow Transplantation; Cell Adhesion; Cell Growth Processes; Cytokines; Graft vs Host Disease; Kaplan-Meier Estimate; Lovastatin; Lymph Nodes; Lymphocyte Activation; Lymphocyte Function-Associated Antigen-1; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Peyer's Patches; T-Lymphocytes

2009